National Academy of Sciences
- About The NAS
- Activities & Programs
- News & Social Media
Tickets are free but limited - online reservations are required. Please join our email list to receive announcements when reservations open.
More events will be added as confirmed.
There is an urgent need to translate genome-era discoveries into clinical utility, but the difficulties in making bench-to-bedside translations may be helped by the nascent field of translational bioinformatics. Dr. Butte's lab at Stanford builds and applies tools that convert trillions points of molecular, clinical, and epidemiological data -- measured by researchers and clinicians over the past decade and now commonly termed “big data” -- into diagnostics, therapeutics, and new insights into disease. This talk will highlight how publicly-available molecular measurements to find new uses for drugs including drug repositioning for inflammatory bowel disease, discovering new treatable inflammatory mechanisms of disease in type 2 diabetes, and how the next generation of biotech companies might even start in your garage.
Atul Butte, Stanford University School of Medicine
Friends of Distinctive Voices reception immediately following the lecture
After decades of planning and a 9-year journey, the New Horizons spacecraft will reach Pluto on July 14, 2015, providing our first close-up view of the Kuiper Belt Object and its five moons.
Fran Bagenal, Professor of Astrophysical and Planetary Sciences
Laboratory for Atmospheric and Space Physics, University of Colorado
Cancer Immunoediting is the process by which the immune system controls and shapes cancer. In its most complex form, cancer immunoediting occurs in three phases: Elimination (the host protective phase of the process), Equilibrium (where tumor cells that survive immune elimination are maintained in a state of functional tumor dormancy) and Escape (where clinically apparent tumors emerge because immune sculpting of the tumor cells has produced variants that display either reduced immunogenicity or enhanced immunosuppressive activity).
Robert Schreiber (NAS), Washington University School of Medicine
This lecture examines how people from different groups, being threatened by different stereotypes, can have quite different experiences in the same situation.
Claude M. Steele, (NAS) Executive Vice Chancellor and Provost at the University of California, Berkeley